StemGen Stock

StemGen EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of StemGen (SGNI) as of Aug 13, 2026 is -4.01. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -15.55 — a change of -74.20% (higher).

EV/FCF

-4.01

YoY

-74.20%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of StemGen is 2026 -4.01 . EV/FCF (Enterprise Value to Free Cash Flow) of StemGen was 2025 -15.55 . It decreases by -74.20% higher compared to the previous year.
Access this data via the Eulerpool API

StemGen Stock analysis

What does StemGen do? StemGen Inc. is a biotechnology company founded in 2005, headquartered in California, USA. The company specializes in the development and research of stem cell products for medical purposes. StemGen Inc. is one of the leading companies in the field of stem cell research. StemGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StemGen stock

EV/FCF (Enterprise Value to Free Cash Flow) of StemGen is -4.01 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of StemGen changed from -15.55 to -4.01, representing a -74.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) StemGen since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s StemGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — StemGen

All Key Metrics — StemGen